AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INSULINE GLARGINE
7 registrations across 3 African markets— 3 active
Markets with INSULINE GLARGINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SEMGLEE Solution injectable / 100 UI/ml | 🇹🇳Tunisia | VIATRIS LIMITED | expired | Jan 2023 |
| GLARGEN Solution injectable / 100 UI/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jun 2021 |
| GLARGEN Solution injectable / 100 UI/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Jun 2021 |
| TOUJEO SOLOSTAR Solution injectable / 300unités/ml | 🇹🇳Tunisia | SANOFI-AVENTIS Deutschland GmbH | expired | Jan 2021 |
| LANTUS ® SOLOSTAR 100U/ML SOL INJ STYLO PRE BT(5x3ML) solution injectable, 5 stylos | 🇲🇬Madagascar | SANOFI-AVENTIS Deutschland | active | — |
| LANTUS SOLASTAR stylo pré-rempli / 100UI/ML | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| LANTUS ® SOLOSTAR 100U/ML SOL INJ STYLO PRE BT(5x3ML) solution injectable, 5 stylos | 🇲🇬Madagascar | SANOFI-AVENTIS Deutschland | active | — |
INSULINE GLARGINE in Africa — Regulatory Overview
INSULINE GLARGINE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Madagascar, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 3 (43%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.